Cor­rect­ed: Op­tum’s biosim­i­lar busi­ness to go af­ter brand-name Hu­mi­ra, Ste­lara in 2025

Op­tum Rx is mov­ing in­to the biosim­i­lar busi­ness with a com­pa­ny it’s call­ing Nu­vaila, and it’s start­ing out with biosim­i­lars to Ab­b­Vie’s block­buster rheuma­toid arthri­tis …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER